指南与共识银屑病与炎症性皮肤病

皮肤硬化性疾病诊疗共识第二部分:硬化性黏液水肿与硬化性水肿

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema.
指南 / 共识 · J Eur Acad Dermatol Venereol · 2024-03-08

本共识为2017年欧洲皮肤病论坛指南的更新,聚焦硬化性黏液水肿与硬化性水肿(Buschke)的诊断与治疗。共识详述特征性临床与组织病理学表现、诊断评分及有助于鉴别诊断的血清自身抗体,并给出更新的一线与进阶治疗策略。

要点

  • 硬化性黏液水肿与硬化性水肿需结合临床、病理和血清自身抗体综合诊断。
  • 共识提供诊断评分与鉴别诊断要点,帮助区分两种硬化性疾病。
  • 治疗策略包括一线与进阶方案,共识给出了更新推荐。

核心结论

  • 共识更新了硬化性黏液水肿与硬化性水肿的诊断与治疗策略,强调临床、病理和血清自身抗体综合评估。

研究设计与样本

  • 本共识为2017年欧洲皮肤病论坛指南的更新,由欧洲皮肤病论坛制定,聚焦硬化性黏液水肿与硬化性水肿。

关键数值与推荐

  • 共识涉及特征性临床与组织病理学特征、诊断评分及最有助于鉴别诊断的血清自身抗体。
  • 共识详细阐述了硬化性皮肤疾病的一线与进阶治疗更新策略。

临床怎么用

  • 临床可依据共识中的诊断评分和血清自身抗体进行鉴别诊断,并按一线与进阶策略选择治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The term 'sclerosing diseases of the skin' comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement and can sometimes be difficult to distinguish from each other. The present consensus provides an update to the 2017 European Dermatology Forum Guidelines, focusing on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodies most useful for differential diagnosis. In addition, updated strategies for the first- and advanced-line therapy of sclerosing skin diseases are addressed in detail. Part 2 of this consensus provides clinicians with an overview of the diagnosis and treatment of scleromyxoedema and scleroedema (of Buschke).

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Knobler R, Geroldinger-Simić M, Kreuter A, et al. Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema. J Eur Acad Dermatol Venereol. 2024. PMID: 38456518. doi:10.1111/jdv.19937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。